MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about psilocybin therapy

Recent news which mentions psilocybin therapy

Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
Tickers NEWS NUMIF
Tags News MDMA Therapy Legal
From Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Tickers ATAI CMND CMPS CYBN
Tags IXHL HUGE Legal
From Benzinga
Washington Doctor Vs. DEA For Lawful Use Of Psilocybin To Treat Terminally Ill Patients
Tickers NEWS
Tags psilocybin therapy Management Psychedelics
From Benzinga
Canadian At-Home Microdose Psilocybin Clinical Trial Finalized, Here Are The Details
Tags Cannabis Psilocybin Microdosing Markets
From Benzinga
Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
Tickers RVVTF
Tags Methamphetamine Use Disorder RVVTF Markets
From Benzinga
Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support
Tickers TRUFF
Tags Psychedelics psilocybin therapy Canadian Controlled Drugs And Substances Act
From Benzinga
Canadian Psychedelics Company Launches Take-Home Psilocybin Trial For Some 300 Participants
Tags Iter Investments Cannabis Market News
From Benzinga
Virginia Psychedelics: Legalizing Medical Use Of Psilocybin Gets A Thumbs Down
Tags News Psychedelics Legalization virginia
From Benzinga
2023 Could Be Make Or Break For Psychedelics In Missouri, This GOP Lawmaker Is Pushing For Change
Tags Cannabis Markets Market News
From Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
Tickers ATAI AWKNF CMND CMPS
Tags ENVB Markets CYBN
From Benzinga
Oregon's Final Rules For Psilocybin Services Are Ready, Learn What To Expect
Tags Benzinga Oregon Health Authority Markets
From Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
Tickers KONEF NMLSF
Tags Markets NMLSF KONEF
From Benzinga
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
Tags News psilocybin therapy Psychedelics
From Benzinga
Potential Road To At-Home Psychedelics Use Permits: Low Dosing's Positive Outcomes In Phase 1 Trial
Tags Benzinga Cannabis Markets
From Benzinga
Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far
Tickers CMPS
Tags Cannabis Market News Benzinga
From Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
Tickers CSA DEA
Tags Dr/ Sunil Aggarwal Legal RTT
From Benzinga
In Oregon You Can Get Trained To Be A Licensed Psilocybin Therapy Provider
Tags News psilocybin therapy Psychedelics
From Benzinga
Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes
Tags Psychedelics Nicole Di Monda Health Care
From Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying
Tickers CMPS
Tags psilocybin therapy Anorexia Nervosa Psychedelics
From Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation
Tags Benzinga USDA Cannabis
From Benzinga
Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
Tickers RVVTF
Tags Dr/ Christopher Nicholas psilocybin therapy LTS LOHMANN Therapie/Systeme AG
From Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
Tickers MSSTF
Tags MHRA Clerkenwell Health psilocybin therapy
From Benzinga
Psychedelics Companies Are Teaming Up To Offer Access Veterans
Tickers AWKNF RVLWF
Tags Management News military veterans
From Benzinga
Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees
Tickers ATAI
Tags Cathie Wood ATAI News
From Benzinga
Study Finds Psilocybin Anti-Depression Effects Last At Least One Year
Tags contributors Benzinga Market News
From Benzinga
The Case For Psilocybin Therapy And Depression
Tags contributors Benzinga Market News
From Benzinga
ATAI Life Sciences Announces New Program To Discover Next-Generation Mental Health Treatments
Tickers ATAI
Tags General psychedelics ATAI
From Benzinga
Psilocybin Therapy Combined With SSRI Antidepressants Is Possible, COMPASS Study Confirms
Tickers CMPS
Tags psilocybin therapy psilocybin therapy for depression CMPS
From Benzinga
Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
Tickers ATAI CMPS
Tags Benzinga Market News Peter Thiel
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story